Circ-AKT3 regulates temozolomide (TMZ) resistance in glioblastoma (GBM) by regulating the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathways and cancer stem cell characteristics[37]. The gene discussed is AKT1; the disease is glioblastoma.